Related Experiment Video
Updated: May 23, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
[Uric acid, atherosclerosis and vascular calcifications in chronic kidney disease]
Luis D'Marco1, Irene García, Claudia Vega
1Hospital Universitario Ruiz y Páez, Servicio de Nefrología, Ciudad Bolívar, Caracas, Venezuela. luisgerardodg@hotmail.com
Insights
High uric acid levels in dialysis patients with chronic kidney disease (CKD) are linked to vascular calcification and increased cardiovascular risk. Monitoring uric acid may help predict adverse events in CKD patients.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Context:
- Cardiovascular disease (CVD) increases mortality in chronic kidney disease (CKD) patients.
- Vascular complications, including calcification and atherosclerosis, are primary drivers of CVD in CKD.
- Recent research highlights the association between uric acid levels and cardiovascular risk.
Purpose:
- To investigate the relationship between vascular calcification (VC) and atherosclerosis, assessed via carotid ultrasound, and serum uric acid levels in dialysis-dependent CKD patients.
- To determine if elevated uric acid levels correlate with VC and adverse cardiovascular outcomes in this population.
Summary:
- Vascular calcification was present in 56% of patients, and 46% showed atherosclerosis.
- Hypertension and diabetes were associated with increased VC susceptibility.
- Elevated urea and uric acid levels significantly correlated with the presence of VC (p=0.01 and p=0.04, respectively).
- Adverse cardiovascular events were more common in patients with atherosclerosis and VC (p=0.01).
Impact:
- This study demonstrates that uric acid levels exceeding 6 mg/dL are associated with a higher risk of vascular calcification and cardiovascular adverse events in CKD patients undergoing dialysis.
- Findings suggest that uric acid may serve as a predictive biomarker for cardiovascular complications in CKD patients on dialysis.
Abstract:
Abstract. Epidemiological and clinical studies have shown that cardiovascular disease is associated with an increase in mortality in patients with chronic kidney disease (CKD). Vascular complications are mainly secondary to calcification and atherosclerosis. Interest in the association between uric acid levels and cardiovascular risk has been renewed in recent years. The objective of this research was to determine the relation between vascular calcification (VC) and atherosclerosis, through carotid ultrasound, with uric acid levels in patients with CKD in dialysis. VCs were observed in 56% of patients, 46% had ultrasound criteria for atherosclerosis with an overall average of 0.89 mm (SD +/- 0.28), being higher in patients with hypertension and diabetes; this group also showed increased susceptibility to VC (p = 0.01). The levels of urea (141.3 mg/dL) (p = 0.01) and uric acid (6.9 mg/dL) (p = 0.04) showed significant association with the presence of VC. Adverse cardiovascular events were observed mainly in patients with atherosclerosis and VC (p = 0.01). This investigation showed that an increase in uric acid levels above 6 mg/dL is associated with an increased risk of calcification and cardiovascular adverse events in CKD patients in dialysis.
Related Concept Videos
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Urinary Tract Calculi I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Urinary Tract Calculi III: Medical Management
Chronic Kidney Disease III: Interprofessional Care

